Celgene Corporation
Celgene Reports Record Second Quarter 2008 Product Sales and Operating Profits
Published in Biotech Business Week, August 11th, 2008
-- Non-GAAP Total Revenues Increased 63 Percent to $566.6 Million; GAAP Total Revenues $571.5 Million
-- REVLIMID(R) Net Product Sales Increased 80 Percent to $325.8 Million
-- Global THALOMID(R)/Thalidomide Net Product Sales Reached $131.6 Million
-- VIDAZA(R) Net Product Sales Achieved $59.7 Million
-- Non-GAAP Operating Income Increased 60 Percent to $207.0 Million; GAAP Operating Income $140.0 Million
-- Non-GAAP Net Income Increased to $172.7 Million; GAAP Net Income $119.9 Million
-- Non-GAAP...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- American Cancer Society
Hip bone density helps predict breast cancer risk - American Cancer Society
Prostate cancer patients undergoing hormone therapy may experience cognitive effects - American Society for Gastrointestinal Endoscopy
Endoscopic circumferential ablation promising for Barrett's esophagus with high-grade dysplasia - BioMed Central
Cholesterol-lowering drug boosts bone repair - BioMed Central
Frankincense provides relief to arthritis sufferers - BioMed Central
Gummy bears that fight plaque - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
